Jin Y, Yuan H, Mehta I, Ezenwa O, Morel P
J Immunol. 2023; 212(4):541-550.
PMID: 38117282
PMC: 10872740.
DOI: 10.4049/jimmunol.2300511.
Zhang Y, Jin Y, Wang H, He L, Zhang Y, Liu Q
Int J Gen Med. 2023; 16:5017-5030.
PMID: 37942472
PMC: 10629397.
DOI: 10.2147/IJGM.S435041.
Wiencke J, Zhang Z, Koestler D, Salas L, Molinaro A, Christensen B
Epigenetics. 2021; 17(3):335-355.
PMID: 33783321
PMC: 8920245.
DOI: 10.1080/15592294.2021.1900027.
Malissen B
Cell Res. 2020; 30(11):948-949.
PMID: 33057136
PMC: 7785027.
DOI: 10.1038/s41422-020-00420-6.
Radinsky O, Edri A, Brusilovsky M, Fedida-Metula S, Sobarzo A, Gershoni-Yahalom O
Sci Rep. 2017; 7(1):6054.
PMID: 28729706
PMC: 5519693.
DOI: 10.1038/s41598-017-06226-8.
Quantitative proteomics analysis of signalosome dynamics in primary T cells identifies the surface receptor CD6 as a Lat adaptor-independent TCR signaling hub.
Roncagalli R, Hauri S, Fiore F, Liang Y, Chen Z, Sansoni A
Nat Immunol. 2014; 15(4):384-392.
PMID: 24584089
PMC: 4037560.
DOI: 10.1038/ni.2843.
Markers of nonselective and specific NK cell activation.
Fogel L, Sun M, Geurs T, Carayannopoulos L, French A
J Immunol. 2013; 190(12):6269-76.
PMID: 23656738
PMC: 3679313.
DOI: 10.4049/jimmunol.1202533.
The adaptor protein SAP directly associates with CD3ζ chain and regulates T cell receptor signaling.
Proust R, Bertoglio J, Gesbert F
PLoS One. 2012; 7(8):e43200.
PMID: 22912825
PMC: 3418226.
DOI: 10.1371/journal.pone.0043200.
Altered expression of the TCR signaling related genes CD3 and FcεRIγ in patients with aplastic anemia.
Li B, Liu S, Niu Y, Fang S, Wu X, Yu Z
J Hematol Oncol. 2012; 5:6.
PMID: 22401598
PMC: 3359239.
DOI: 10.1186/1756-8722-5-6.
Basic residues in the T-cell receptor ζ cytoplasmic domain mediate membrane association and modulate signaling.
Zhang H, Cordoba S, Dushek O, Anton van der Merwe P
Proc Natl Acad Sci U S A. 2011; 108(48):19323-8.
PMID: 22084078
PMC: 3228420.
DOI: 10.1073/pnas.1108052108.
The CD3 zeta subunit contains a phosphoinositide-binding motif that is required for the stable accumulation of TCR-CD3 complex at the immunological synapse.
Deford-Watts L, Dougall D, Belkaya S, Johnson B, Eitson J, Roybal K
J Immunol. 2011; 186(12):6839-47.
PMID: 21543646
PMC: 3110614.
DOI: 10.4049/jimmunol.1002721.
Role of CD45 signaling pathway in galactoxylomannan-induced T cell damage.
Pericolini E, Gabrielli E, Bistoni G, Cenci E, Perito S, Chow S
PLoS One. 2010; 5(9):e12720.
PMID: 20856869
PMC: 2939064.
DOI: 10.1371/journal.pone.0012720.
ITAM-mediated signaling by the T-cell antigen receptor.
Love P, Hayes S
Cold Spring Harb Perspect Biol. 2010; 2(6):a002485.
PMID: 20516133
PMC: 2869518.
DOI: 10.1101/cshperspect.a002485.
Evidence for a functional sidedness to the alphabetaTCR.
Kuhns M, Girvin A, Klein L, Chen R, Jensen K, Newell E
Proc Natl Acad Sci U S A. 2010; 107(11):5094-9.
PMID: 20202921
PMC: 2841884.
DOI: 10.1073/pnas.1000925107.
The right team at the right time to go for a home run: tyrosine kinase activation by the TCR.
Weiss A
Nat Immunol. 2010; 11(2):101-4.
PMID: 20084063
DOI: 10.1038/ni0210-101.
T cell activation.
Smith-Garvin J, Koretzky G, Jordan M
Annu Rev Immunol. 2009; 27:591-619.
PMID: 19132916
PMC: 2740335.
DOI: 10.1146/annurev.immunol.021908.132706.
Engineering higher affinity T cell receptors using a T cell display system.
Chervin A, Aggen D, Raseman J, Kranz D
J Immunol Methods. 2008; 339(2):175-84.
PMID: 18854190
PMC: 2680719.
DOI: 10.1016/j.jim.2008.09.016.
Targeting of tumor cells by lymphocytes engineered to express chimeric receptor genes.
Baxevanis C, Papamichail M
Cancer Immunol Immunother. 2004; 53(10):893-903.
PMID: 15168086
PMC: 11032905.
DOI: 10.1007/s00262-004-0523-y.
T cell receptor zeta reconstitution fails to restore responses of T cells rendered hyporesponsive by tumor necrosis factor alpha.
Clark J, Annenkov A, Panesar M, Isomaki P, Chernajovsky Y, Cope A
Proc Natl Acad Sci U S A. 2004; 101(6):1696-701.
PMID: 14745016
PMC: 341820.
DOI: 10.1073/pnas.0308231100.
Defective expression and tyrosine phosphorylation of the T cell receptor zeta chain in peripheral blood T cells from systemic lupus erythematosus patients.
Pang M, Setoyama Y, Tsuzaka K, Yoshimoto K, Amano K, Abe T
Clin Exp Immunol. 2002; 129(1):160-8.
PMID: 12100036
PMC: 1906428.
DOI: 10.1046/j.1365-2249.2002.01833.x.